Bone Biologics (BBLGW) Non-Current Debt (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Non-Current Debt for 2 consecutive years, with $7.2 million as the latest value for Q3 2017.
- Quarterly Non-Current Debt rose 20.76% to $7.2 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $7.2 million through Sep 2017, up 20.76% year-over-year, with the annual reading at $7.6 million for FY2016, N/A changed from the prior year.
- Non-Current Debt for Q3 2017 was $7.2 million at Bone Biologics, up from $6.9 million in the prior quarter.
- The five-year high for Non-Current Debt was $7.6 million in Q4 2016, with the low at $5.3 million in Q1 2016.